Business Update
Ciphergen announces second development program with Quest Diagnostics
Published in Blood Weekly, February 1st, 2007
In addition to the current ovarian tumor triage test, Quest Diagnostics will now also assist Ciphergen in the development of a blood-based assay for the detection of peripheral artery disease (PAD).
"We are pleased that Quest Diagnostics has chosen the development of this PAD diagnostic test as the second of three programs that we will jointly develop," said Gail S. Page, president and CEO of Ciphergen. "The first program under our strategic alliance, an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-02-01)
More Articles from Blood Weekly
- Dengue Virus Epidemiology
Study results from Pedro Kouri Tropical Medicine Institute broaden understanding of dengue virus epidemiology - Falciparum Malaria
New falciparum malaria in children study results reported from Institute of Pediatrics - Pneumonia Therapy
Findings from Samsung Medical Center, Department of Pediatrics broaden understanding of pneumonia therapy - Proteomics
Researchers from Pennsylvania State University detail new studies and findings in the area of proteomics - Sepsis
Reports from University of Copenhagen describe recent advances in sepsis - Sepsis Genetics
Study data from University of Newcastle-upon-Tyne, Department of Anaesthesia update knowledge of sepsis genetics - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
